DRDR.TO
MCI Onehealth Technologies Inc. [DRDR.TO] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
DRDR.TO Stock Summary
In the News
DRDR.TO Financial details
Company Rating
-
Market Cap
49.43M
Income
-24.2M
Revenue
51.74M
Book val./share
0.14
Cash/share
0.04
Dividend
-
Dividend %
-
Employees
340
Optionable
No
Shortable
Yes
Earnings
13 Nov 2023
P/E
-1.18
Forward P/E
-
PEG
-0.53
P/S
0.96
P/B
3.89
P/C
19
P/FCF
-6.47
Quick Ratio
0.31
Current Ratio
0.34
Debt / Equity
2.55
LT Debt / Equity
1.04
-
-
EPS (TTM)
-0.4
EPS next Y
-
EPS next Q
-
EPS this Y
27.27%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
172.41%
Revenue last 5Y
3.39%
Revenue Q/Q
-16.43%
EPS Q/Q
-
-
-
-
-
SMA20
55.32%
SMA50
143.33%
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-60%
ROE
-177%
ROC
-1%
Gross Margin
31%
Oper. Margin
-38%
Profit Margin
-47%
Payout
-
Shs Outstand
89.87M
Shs Float
18M
-
-
-
-
Target Price
-
52W Range
0.085-1.05
52W High
-
52W Low
-
RSI
58.48
Rel Volume
5.29
Avg Volume
43.28K
Volume
229.01K
Perf Week
15.15%
Perf Month
90%
Perf Quarter
-
Perf Half Y
406.67%
-
-
-
-
Beta
-0.591678
-
-
Volatility
0.05%, 0.15%
Prev Close
2.7%
Price
0.76
Change
-1.3%
DRDR.TO Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
| Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 0.55 | 0.56 | 0.47 | 1 | 1.06 | |
| Net income per share | 0 | 0 | -0.01 | -0.33 | -0.42 | |
| Operating cash flow per share | 0.04 | 0.04 | 0.05 | -0.15 | -0.17 | |
| Free cash flow per share | 0.04 | 0.04 | 0.05 | -0.2 | -0.19 | |
| Cash per share | 0.02 | 0.02 | 0.02 | 0.16 | 0.04 | |
| Book value per share | 0.03 | 0.03 | 0 | 0.61 | 0.24 | |
| Tangible book value per share | 0.02 | 0.02 | 0 | 0.18 | -0.16 | |
| Share holders equity per share | 0.03 | 0.03 | 0 | 0.61 | 0.24 | |
| Interest debt per share | 0.22 | 0.2 | 0.17 | 0.31 | 0.36 | |
| Market cap | 370.64M | 370.64M | 370.64M | 60M | 30.05M | |
| Enterprise value | 386.92M | 385.46M | 383.58M | 67.2M | 46.05M | |
| P/E ratio | -1.62K | -3.08K | -360.19 | -3.83 | -1.42 | |
| Price to sales ratio | 8.23 | 8.01 | 9.61 | 1.25 | 0.56 | |
| POCF ratio | 101.23 | 115.35 | 87.79 | -8.45 | -3.6 | |
| PFCF ratio | 106.84 | 119.9 | 92.94 | -6.34 | -3.16 | |
| P/B Ratio | 163.89 | 173.1 | 3.25K | 2.03 | 2.55 | |
| PTB ratio | 163.89 | 173.1 | 3.25K | 2.03 | 2.55 | |
| EV to sales | 8.59 | 8.33 | 9.94 | 1.41 | 0.87 | |
| Enterprise value over EBITDA | 110.53 | 105.88 | 181.19 | -5.54 | -3.05 | |
| EV to operating cash flow | 105.68 | 119.96 | 90.85 | -9.47 | -5.52 | |
| EV to free cash flow | 111.53 | 124.69 | 96.18 | -7.1 | -4.84 | |
| Earnings yield | 0 | 0 | 0 | -0.26 | -0.7 | |
| Free cash flow yield | 0.01 | 0.01 | 0.01 | -0.16 | -0.32 | |
| Debt to equity | 7.61 | 7.45 | 121.34 | 0.49 | 1.48 | |
| Debt to assets | 0.68 | 0.7 | 0.62 | 0.24 | 0.38 | |
| Net debt to EBITDA | 4.65 | 4.07 | 6.11 | -0.59 | -1.06 | |
| Current ratio | 0.54 | 0.59 | 0.54 | 1.14 | 0.44 | |
| Interest coverage | 0.63 | 0.98 | -1.67 | -35.57 | -41.71 | |
| Income quality | -15.12 | -26.65 | -4.11 | 0.46 | 0.4 | |
| Dividend Yield | 0 | 0 | 0.01 | 0.01 | 0 | |
| Payout ratio | 0 | 0 | -1.95 | -0.03 | 0 | |
| Sales general and administrative to revenue | 0.3 | 0.29 | 0.32 | 0.63 | 0.5 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0.15 | |
| Intangibles to total assets | 0.01 | 0.01 | 0.03 | 0.37 | 0.47 | |
| Capex to operating cash flow | -0.05 | -0.04 | -0.06 | 0.33 | 0.14 | |
| Capex to revenue | 0 | 0 | -0.01 | -0.05 | -0.02 | |
| Capex to depreciation | -0.06 | -0.04 | -0.08 | -0.55 | -0.22 | |
| Stock based compensation to revenue | 0.01 | 0.01 | 0.02 | 0.13 | 0.09 | |
| Graham number | 0.04 | 0.03 | 0.02 | 2.12 | 1.49 | |
| ROIC | 0.01 | 0.06 | -0.02 | -0.27 | -0.55 | |
| Return on tangible assets | -0.01 | -0.01 | -0.05 | -0.41 | -0.87 | |
| Graham Net | -0.23 | -0.21 | -0.22 | -0.36 | -0.52 | |
| Working capital | -3.71M | -2.93M | -4.97M | 2.02M | -10.78M | |
| Tangible asset value | 2.05M | 1.98M | -403K | 8.69M | -7.83M | |
| Net current asset value | -18.42M | -16.24M | -16.34M | -13.17M | -23.53M | |
| Invested capital | 7.61 | 7.45 | 121.34 | 0.49 | 1.48 | |
| Average receivables | 0 | 2.86M | 3.13M | 4.98M | 5.98M | |
| Average payables | 0 | 2.68M | 3.61M | 5.71M | 6.24M | |
| Average inventory | 0 | 0 | 0 | 0 | 0 | |
| Days sales outstanding | 25.12 | 20.68 | 34.42 | 48.3 | 38.59 | |
| Days payables outstanding | 34.07 | 30.25 | 66.09 | 75.3 | 56.99 | |
| Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
| Receivables turnover | 14.53 | 17.65 | 10.61 | 7.56 | 9.46 | |
| Payables turnover | 10.71 | 12.06 | 5.52 | 4.85 | 6.4 | |
| Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
| ROE | -0.1 | -0.06 | -9.03 | -0.53 | -1.79 | |
| Capex per share | 0 | 0 | 0 | -0.05 | -0.02 |
Quarterly Fundamentals Overview
Last date of statement is 2023-03-31 for Q1
| Metric | History | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 0.26 | 0.28 | 0.25 | 0 | 0.22 | |
| Net income per share | -0.09 | -0.08 | -0.18 | 0 | -0.14 | |
| Operating cash flow per share | -0.05 | -0.05 | -0.04 | 0 | -0.02 | |
| Free cash flow per share | -0.06 | -0.06 | -0.05 | 0 | -0.02 | |
| Cash per share | 0.08 | 0.03 | 0.04 | 0 | 0.04 | |
| Book value per share | 0.5 | 0.43 | 0.27 | 0 | 0.14 | |
| Tangible book value per share | 0.09 | 0.03 | -0.13 | 0 | -0.22 | |
| Share holders equity per share | 0.5 | 0.43 | 0.27 | 0 | 0.14 | |
| Interest debt per share | 0.3 | 0.31 | 0.36 | 0 | 0.37 | |
| Market cap | 68.1M | 64.6M | 46.57M | 0 | 25.97M | |
| Enterprise value | 79.74M | 79.01M | 63.2M | 16.01M | 43.26M | |
| P/E ratio | -3.94 | -3.86 | -1.29 | 0 | -0.87 | |
| Price to sales ratio | 5.23 | 4.68 | 3.7 | 0 | 2.25 | |
| POCF ratio | -26.58 | -26.25 | -20.71 | 0 | -23.43 | |
| PFCF ratio | -22.79 | -22.57 | -18.21 | 0 | -23.35 | |
| P/B Ratio | 2.74 | 2.97 | 3.4 | 0 | 3.54 | |
| PTB ratio | 2.74 | 2.97 | 3.4 | 0 | 3.54 | |
| EV to sales | 6.12 | 5.72 | 5.02 | 1.16 | 3.75 | |
| Enterprise value over EBITDA | -21.56 | -20.25 | -16.69 | -4.32 | -14.18 | |
| EV to operating cash flow | -31.12 | -32.11 | -28.1 | -14.91 | -39.04 | |
| EV to free cash flow | -26.69 | -27.61 | -24.72 | -14.46 | -38.9 | |
| Earnings yield | -0.06 | -0.06 | -0.19 | 0 | -0.29 | |
| Free cash flow yield | -0.04 | -0.04 | -0.05 | 0 | -0.04 | |
| Debt to equity | 0.61 | 0.71 | 1.31 | 1.48 | 2.55 | |
| Debt to assets | 0.26 | 0.29 | 0.38 | 0.38 | 0.46 | |
| Net debt to EBITDA | -3.15 | -3.7 | -4.39 | -4.32 | -5.67 | |
| Current ratio | 0.85 | 0.59 | 0.54 | 0.44 | 0.34 | |
| Interest coverage | -42.05 | -37.59 | -43.28 | -45.12 | -11.85 | |
| Income quality | 0.61 | 0.58 | 0.25 | 0.31 | 0.15 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0.51 | 0.47 | 0.54 | 0.5 | 0.48 | |
| Research and developement to revenue | 0.14 | 0.16 | 0.15 | 0.16 | 0.16 | |
| Intangibles to total assets | 0.39 | 0.41 | 0.46 | 0.47 | 0.51 | |
| Capex to operating cash flow | 0.17 | 0.16 | 0.14 | 0.03 | 0 | |
| Capex to revenue | -0.03 | -0.03 | -0.02 | 0 | 0 | |
| Capex to depreciation | -0.35 | -0.32 | -0.22 | -0.02 | 0 | |
| Stock based compensation to revenue | 0.09 | 0.08 | 0.08 | 0.12 | 0.06 | |
| Graham number | 0.98 | 0.9 | 1.05 | 0 | 0.67 | |
| ROIC | -0.08 | -0.08 | -0.19 | -0.12 | -0.12 | |
| Return on tangible assets | -0.12 | -0.13 | -0.35 | -0.15 | -0.37 | |
| Graham Net | -0.44 | -0.49 | -0.54 | 0 | -0.51 | |
| Working capital | -2.1M | -5.94M | -6.2M | -10.78M | -13.62M | |
| Tangible asset value | 4.32M | 1.27M | -6.55M | -7.83M | -11.6M | |
| Net current asset value | -18.98M | -21.96M | -24.94M | -23.53M | -24.39M | |
| Invested capital | 0.61 | 0.71 | 1.31 | 1.48 | 2.55 | |
| Average receivables | 6.2M | 6.02M | 5.27M | 5.09M | 5.08M | |
| Average payables | 7.68M | 8.37M | 7.53M | 6.31M | 7.34M | |
| Average inventory | 0 | 0 | 0 | 0 | 0 | |
| Days sales outstanding | 41.91 | 38.93 | 32.6 | 36.7 | 35.39 | |
| Days payables outstanding | 86.56 | 75.51 | 69.65 | 56.96 | 98.85 | |
| Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
| Receivables turnover | 2.15 | 2.31 | 2.76 | 2.45 | 2.54 | |
| Payables turnover | 1.04 | 1.19 | 1.29 | 1.58 | 0.91 | |
| Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
| ROE | -0.17 | -0.19 | -0.66 | -0.3 | -1.01 | |
| Capex per share | -0.01 | -0.01 | -0.01 | 0 | 0 |
DRDR.TO Frequently Asked Questions
What is MCI Onehealth Technologies Inc. stock symbol ?
MCI Onehealth Technologies Inc. is a CA stock , located in Toronto of On and trading under the symbol DRDR.TO
What is MCI Onehealth Technologies Inc. stock quote today ?
MCI Onehealth Technologies Inc. stock price is $0.76 today.
Is MCI Onehealth Technologies Inc. stock public?
Yes, MCI Onehealth Technologies Inc. is a publicly traded company.
Company Profile
- Volume Average 43.28K
- Market Capitalization 49.43M
- Employee 340
- CEO Dr. Alexander Julian Dobranowski
- Headquarters Toronto,ON,CA
- IPO Date 2021-01-06
-
Website
https://www.mcionehealth.com 
MCI Onehealth Technologies Inc., through its subsidiaries, provides healthcare and healthcare related services to patients and the employees of corporate customers in Canada. The company provides its services through a network of 25 brick and mortar clinics, as well as through telehealth/virtual care platform. The company was formerly known as MCI Brighthealth Technologies Inc. and changed its name to MCI Onehealth Technologies Inc. in December 2020. MCI Onehealth Technologies Inc. was incorporated in 2012 and is headquartered in Toronto, Canada.
